BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 25069841)

  • 1. Selective clearance of aberrant tau proteins and rescue of neurotoxicity by transcription factor EB.
    Polito VA; Li H; Martini-Stoica H; Wang B; Yang L; Xu Y; Swartzlander DB; Palmieri M; di Ronza A; Lee VM; Sardiello M; Ballabio A; Zheng H
    EMBO Mol Med; 2014 Sep; 6(9):1142-60. PubMed ID: 25069841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of synaptic activity promotes TFEB-mediated clearance of pathological MAPT/Tau in cellular and mouse models of tauopathies.
    Akwa Y; Di Malta C; Zallo F; Gondard E; Lunati A; Diaz-de-Grenu LZ; Zampelli A; Boiret A; Santamaria S; Martinez-Preciado M; Cortese K; Kordower JH; Matute C; Lozano AM; Capetillo-Zarate E; Vaccari T; Settembre C; Baulieu EE; Tampellini D
    Autophagy; 2023 Feb; 19(2):660-677. PubMed ID: 35867714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A small molecule transcription factor EB activator ameliorates beta-amyloid precursor protein and Tau pathology in Alzheimer's disease models.
    Song JX; Malampati S; Zeng Y; Durairajan SSK; Yang CB; Tong BC; Iyaswamy A; Shang WB; Sreenivasmurthy SG; Zhu Z; Cheung KH; Lu JH; Tang C; Xu N; Li M
    Aging Cell; 2020 Feb; 19(2):e13069. PubMed ID: 31858697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TFEB Overexpression in the P301S Model of Tauopathy Mitigates Increased PHF1 Levels and Lipofuscin Puncta and Rescues Memory Deficits.
    Wang H; Wang R; Carrera I; Xu S; Lakshmana MK
    eNeuro; 2016; 3(2):. PubMed ID: 27257626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Celastrol, a TFEB (transcription factor EB) agonist, is a promising drug candidate for Alzheimer disease.
    Zhang W; Wang J; Yang C
    Autophagy; 2022 Jul; 18(7):1740-1742. PubMed ID: 35253615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TFEB enhances astroglial uptake of extracellular tau species and reduces tau spreading.
    Martini-Stoica H; Cole AL; Swartzlander DB; Chen F; Wan YW; Bajaj L; Bader DA; Lee VMY; Trojanowski JQ; Liu Z; Sardiello M; Zheng H
    J Exp Med; 2018 Sep; 215(9):2355-2377. PubMed ID: 30108137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ouabain activates transcription factor EB and exerts neuroprotection in models of Alzheimer's disease.
    Song HL; Demirev AV; Kim NY; Kim DH; Yoon SY
    Mol Cell Neurosci; 2019 Mar; 95():13-24. PubMed ID: 30594669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cargo receptor SQSTM1 ameliorates neurofibrillary tangle pathology and spreading through selective targeting of pathological MAPT (microtubule associated protein tau).
    Xu Y; Zhang S; Zheng H
    Autophagy; 2019 Apr; 15(4):583-598. PubMed ID: 30290707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electroacupuncture ameliorates beta-amyloid pathology and cognitive impairment in Alzheimer disease via a novel mechanism involving activation of TFEB (transcription factor EB).
    Zheng X; Lin W; Jiang Y; Lu K; Wei W; Huo Q; Cui S; Yang X; Li M; Xu N; Tang C; Song JX
    Autophagy; 2021 Nov; 17(11):3833-3847. PubMed ID: 33622188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TFEB Participates in the Aβ-Induced Pathogenesis of Alzheimer's Disease by Regulating the Autophagy-Lysosome Pathway.
    Zhang YD; Zhao JJ
    DNA Cell Biol; 2015 Nov; 34(11):661-8. PubMed ID: 26368054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TFEB-vacuolar ATPase signaling regulates lysosomal function and microglial activation in tauopathy.
    Wang B; Martini-Stoica H; Qi C; Lu TC; Wang S; Xiong W; Qi Y; Xu Y; Sardiello M; Li H; Zheng H
    Nat Neurosci; 2024 Jan; 27(1):48-62. PubMed ID: 37985800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
    Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL
    J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TFEB in Alzheimer's disease: From molecular mechanisms to therapeutic implications.
    Gu Z; Cao H; Zuo C; Huang Y; Miao J; Song Y; Yang Y; Zhu L; Wang F
    Neurobiol Dis; 2022 Oct; 173():105855. PubMed ID: 36031168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TFEB regulates lysosomal exocytosis of tau and its loss of function exacerbates tau pathology and spreading.
    Xu Y; Du S; Marsh JA; Horie K; Sato C; Ballabio A; Karch CM; Holtzman DM; Zheng H
    Mol Psychiatry; 2021 Oct; 26(10):5925-5939. PubMed ID: 32366951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Autophagy-Lysosomal Pathway in Neurodegeneration: A TFEB Perspective.
    Martini-Stoica H; Xu Y; Ballabio A; Zheng H
    Trends Neurosci; 2016 Apr; 39(4):221-234. PubMed ID: 26968346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic background modifies neurodegeneration and neuroinflammation driven by misfolded human tau protein in rat model of tauopathy: implication for immunomodulatory approach to Alzheimer's disease.
    Stozicka Z; Zilka N; Novak P; Kovacech B; Bugos O; Novak M
    J Neuroinflammation; 2010 Oct; 7():64. PubMed ID: 20937161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.
    Helboe L; Egebjerg J; Barkholt P; Volbracht C
    Brain Res; 2017 Jun; 1665():22-35. PubMed ID: 28411086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trehalose induces autophagy via lysosomal-mediated TFEB activation in models of motoneuron degeneration.
    Rusmini P; Cortese K; Crippa V; Cristofani R; Cicardi ME; Ferrari V; Vezzoli G; Tedesco B; Meroni M; Messi E; Piccolella M; Galbiati M; Garrè M; Morelli E; Vaccari T; Poletti A
    Autophagy; 2019 Apr; 15(4):631-651. PubMed ID: 30335591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of TFEB in Diseases Associated with Lysosomal Dysfunction.
    Pan HY; Valapala M
    Adv Exp Med Biol; 2023; 1415():319-325. PubMed ID: 37440051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.